Study and Prioritization of Factors Affecting the Increase in the Number of Patients with Coronavirus from the Perspective of the People of Alborz Province (using Friedman test)
(Case study Alborz province)

Dekamini, Fatemeh; Ehsanifar, Mohammad

doi:10.30699/ijmm.15.2.140

year 15, Issue 2 (March - April 2021) Iran J Med Microbiol 2021, 15(2): 140-172 | Back to browse issues page

‎ 10.30699/ijmm.15.2.140

Mendeley

Zotero

RefWorks

Dekamini F, Ehsanifar M. Study and Prioritization of Factors Affecting the Increase in the Number of Patients with Coronavirus from the Perspective of the People of Alborz Province (using Friedman test) (Case study Alborz province). Iran J Med Microbiol 2021; 15 (2) :140-172
URL: http://ijmm.ir/article-1-1245-en.html

Study and Prioritization of Factors Affecting the Increase in the Number of Patients with Coronavirus from the Perspective of the People of Alborz Province (using Friedman test) (Case study Alborz province)

Fatemeh Dekamini

¹, Mohammad Ehsanifar²

1- Department of Industrial Management, Islamic Azad University Faculty of Management, Arak, Iran. , s_dekamin@yahoo.com
2- Department of Industrial Engineering, Islamic Azad University of Arak, Arak, Iran

Abstract: (6446 Views)

Background and Objective: In general, examining and prioritizing the factors influencing the increase of the new COVID-19 virus is essential for the survival of the world. The purpose of this study is to rank the effective factors (12 identified factors) on the increase of Coronavirus from the perspective of the people of Alborz province, in the second half of 2020, in this province.
Materials and Methods: This study was conducted using the Friedman test. In this applied research, A questionnaire was used, which was randomly distributed among 402 people (sample size using was derived using the Cochran's formula).
Results: In the forthcoming research, three fundamental questions were answered:
1) what are the factors influencing the increase in the number of patients with COVID-19 desease in Alborz province? This was done studying the literature and announcements of the Central Headquarters for Corona and library studies and "12" factors were identified, (other factors may also be involved),
2) considering the above factors, which factor is the first priority?
3) what are the basic solutions to reduce the number of patients?
Conclusion: Based on the results, the increase in the number of people infected with the Corona virus is affected by 12 factors from the perspective of the people of Alborz province. Regarding the importance of each of these "12" factors, the most effective factor, was identified as insufficiency of personal hygiene. The results of this research can help with monitoring, reducing the number of people who are infected, and creating and maintaining better conditions in this province and other parts of the country, and even other countries.

Keywords: Prioritization, A rise in patient numbers, Coronavirus infections, Corona outbreak in Alborz province, Friedman test

Full-Text [PDF 1438 kb] (1914 Downloads) | | Full-Text (HTML) (1619 Views)

Type of Study: Original Research Article | Subject: Medical Virology
Received: 2020/11/11 | Accepted: 2021/02/20 | ePublished: 2021/04/9

References

1. Wu F ZS, Bin Y, Chen YM, Wang W, Song ZG, Hu Y, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020. [DOI:10.1038/s41586-020-2202-3] [PMID] [PMCID]

2. Zhou P YX, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new Coronavirus of probable bat origin. Nature. 2020.

3. Gorbalenya AE. Severe acute respiratory syndrome-related Coronavirus-The species and its viruses, a statement of the Coronavirus Study Group. BioRxiv. 2020.

4. National Health Commission's briefing on the pneumonia epidemic situation. Released on 23 Feb. 2020.

5. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-71. 2020. Available from: https://www.who.int/ docs/default source/Coronaviruse/situationreports/ 20200331-sitrep-71- COVID 19.pdf?sfvrsn=4360e92b_8.

6. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020 Apr 1;10(2):102-8. [DOI:10.1016/j. jpha.2020.03.001] [PMID]. [DOI:10.1016/j.jpha.2020.03.001] [PMID] [PMCID]

7. Wang C HP, Hayden FG, Gao GF. A novel Coronavirus outbreak of global health concern. Lancet. 2020 Feb 15;395(10223):470-3. [DOI:10.1016/S0140-6736(20)30185-9]

8. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020 Apr. [DOI:10.1101/2020.01.26.919985]

9. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020 Mar 3;12(1):1-6. [DOI:10.1038/s41368-020-0075-9] [PMID] [PMCID]

10. Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, et al. Real-time reverse transcription-polymerase chain reaction assay for SARS-associated Coronavirus. Emerg Infect Dis. 2004 Feb;10(2):311. [DOI:10.3201/eid1002.030759] [PMID] [PMCID]

11. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human Coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010 Aug 1;48(8):2940-7. [DOI:10.1128/JCM.00636-10] [PMID] [PMCID]

12. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G. First case of 2019 novel coronavirus in the United States. New Eng J Med. 2020 Jan 31. [DOI:10.1056/NEJMoa2001191] [PMID] [PMCID]

13. Broxmeyer DL. MD. "Promising antimicrobial hope for "Coronavirus", but is it working against a virus?" Pulm Res Respir Care. 2020; 4:19-28. http://www.academia.edu/download/62957532/Final_Scientia_Promising_ antimicrobrial_hope_SRPRRC-04-00028.pdf

14. Xu Z, Peng C, Shi Y, Zhu Z, Mu K, Wang X, et al. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv. 2020 Jan 1 [DOI:10.1101/2020.01.27.921627]

15. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar 1;59(3):252-6. [DOI:10.1136/thorax.2003.012658] [PMID] [PMCID]

16. Sibbald S, Singer P, Upshur R, Martin D. Priority setting: what constitutes success?conceptual framework for successful priority setting. BMC Health Serv Res. 2009 Dec;9(1):1-2. [DOI:10.1186/1472-6963-9-43] [PMID] [PMCID]

17. Bauer T, Sanders J. Needs assessment of Wisconsin primary care residents and faculty regarding interest in global health training. BMC Med Educ. 2009 Dec;9(1):1-6. [DOI:10.1186/1472-6920-9-36] [PMID] [PMCID]

18. https://www.worldometers.info/Coronavirus/ (access:March,01,2020).

19. Chen Y, Liu Q, Guo D. Emerging Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020 Apr;92(4):418-23. [DOI:10.1002/jmv.25681] [PMID] [PMCID]

20. https://www.irna.ir/news/84061538/

21. Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, et al. Aerosol and surface distribution of severe acute respiratory syndrome Coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis 2020 Jul;26(7):1586. [DOI:10.3201/eid2607.200885] [PMID] [PMCID]

22. Gerami A, Dadgar S, Rakhshan V, Jannati P, Sobouti F. Displacement and force distribution of splinted and tilted mandibular anterior teeth under occlusal loads: an in silico 3D finite element analysis. Prog Orthod. 2016 Dec;17(1):1-0. [DOI:10.1186/s40510-016-0129-x] [PMID] [PMCID]

23. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel Coronavirus infection in China. MedRxiv. 2020 Jan 1. [DOI:10.1101/2020.02.06.20020974]

24. Symptoms of Coronavirus. 2020. Available from: https://www.cdc.gov/Coronavirus/2019- ncov/symptoms-testing/symptoms.html.

25. People who are at higher risk for severe illness. 2020. Available from: https://www. cdc.gov/Coronavirus/2019-ncov/need-extraprecautions/ people-at-higher-risk-old.html.

26. Buja LM, Wolf D, Zhao B, Akkanti B, McDonald M, Lelenwa L, et al. The emerging spectrum of cardiopulmonary pathology of the Coronavirus disease (2019) (COVID-19): report of three autopsies from houston, texas and review of autopsy findings from other united states cities. Cardiovasc Pathol. 2020 Sep 1;48:107233.. [DOI:10.1016/j.carpath.2020.107233] [PMID] [PMCID]

27. Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified Coronavirus may boost cross‐species transmission from snake to human. J Med Virol. 2020.

28. Benvenuto D, Giovannetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new Coronavirus epidemic: evidence for virus evolution. J Med Virol. 2020 Apr;92(4):455-9. [DOI:10.1101/2020.01.24.915157]

29. Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic Coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 2020 Jan 1;9(1):221-36. [DOI:10.1080/22221751.2020.1719902] [PMID] [PMCID]

30. Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel Coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020 Apr;92(4):441-7. [DOI:10.1002/jmv.25689] [PMID] [PMCID]

31. Wu P, Hao X, Lau EH, Wong JY, Leung KS, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel Coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance. 2020 Jan 23;25(3):2000044. [DOI:10.2807/1560-7917.ES.2020.25.3.2000044]

32. Sheng G, Chen P, Wei Y, Yue H, Chu J, Zhao J, et al. Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis. Chest. 2020 May 1;157(5):1175-87. [DOI:10.1016/j.chest.2019.10.032] [PMID] [PMCID]

33. Latridis, T. Fousiani, K. Effects of status and outcome on attributions and just world beliefs: how the social distribution of success and failure may be rationalized. J Exp Soc Psychol, 2009 Feb 1;45(2):415-20. [DOI:10.1016/j.jesp.2008.12.002]

34. Viadero, D. Out-of-school factors seen as key, poverty and potential: out-of school factors and school success. Education week, 2009; 28,(24),5

35. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel Coronavirus infection in China. Med Rxiv. 2020. [DOI:10.1101/2020.02.06.20020974]

36. Wang C HP, Hayden FG, Gao GF. A novel Coronavirus outbreak of global health concern. Lancet. 2020. [DOI:10.1016/S0140-6736(20)30185-9]

37. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020. [DOI:10.1101/2020.01.26.919985]

38. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel Coronavirus infection in China. medRxiv. 2020. [DOI:10.1101/2020.02.06.20020974]

39. Redfearn, G. (2020). Coronavirus outbrean, The Guardian, https://www. theguardian.com.

40. Fukuyama, F., Totalitarianism as a Mindset Can Be Anywhere. The American Interest. 2020. https://www.the-american-interest.com

41. Wu, Cary & Wilkes, Rima & Fairbrother, Malcolm & Giordano, Giuseppe. Social Capital, Trust, and State Coronavirus Testing. Contexts. 2020.

42. Wu, Cary et al. The Dynamics of Trust Before, During and After the COVID-19 Outbreak. Canadian Institutes of Health Research. 2020.

43. Chan JFW, Yuan S, Kok KH, et al. A Familial Cluster Of Pneumonia Associated With The 2019 Novel Coronavirus Indicating Person-To- Person Transmission: A Study Of A Family Cluster. Lancet. 2020; 395(10223): 514-23. [DOI:10.1016/S0140-6736(20)30154-9]

44. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics Of 2019 Novel Coronavirus Infection In China. Medrxiv. In press. 2020.

45. Huang C, Wang Y, Li X, et al. Clinical Features Of Patients Infected With 2019 Novel Coronavirus In Wuhan, China. Lancet. 2020; 395(10223): 497-506. [DOI:10.1016/S0140-6736(20)30183-5]

46. Coronavirus Disease 2019 (COVID-19). CDC. (Accessed February 28, 2020, at https://www.cdc.gov/Coronavirus/2019- Ncov/About/Transmission.Html).